What’s next in peripartum cardiomyopathy investigation?

References

• Tibazarwa K, Sliwa K. Peripartum cardiomyopathy in Africa: challenges in diagnosis, prognosis and therapy. Prog. Cardiovasc. Dis.52(4), 317–325 (2010).
   PubMed Web of Science ®Google Scholar
• Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: causes, diagnosis and treatment. Cleve. Clin. J. Med.76(5), 289–296 (2009).
   PubMed Web of Science ®Google Scholar
• Selle T, Renger I, Labidi S, Bultmann I, Hilfiker-Kleiner D. Reviewing peripartum cardiomyopathy: current state of knowledge. Future Cardiol.5(2), 175–189 (2009).
   PubMedGoogle Scholar
• Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int. J. Cardiol.131, 168–179 (2009).
   PubMed Web of Science ®Google Scholar
• Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet368, 687–693 (2006).
   PubMed Web of Science ®Google Scholar
• Pearson GD, Veille JC, Rahiimtoola S et al. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Offices of Rare Diseases (National Institutes of Health) Workshop recommendations and review. JAMA283, 1183–1188 (2000).
   PubMed Web of Science ®Google Scholar
• Elkayam U, Akhter MW, Singh H et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation111, 2050–2055 (2005).
   PubMed Web of Science ®Google Scholar
• Sundstrom JB, Fett JD, Carraway RD, Ansari AA. Is peripartum cardiomyopathy an organ specific autoimmune disease? Autoimmun. Rev.1, 73–77 (2002).
   PubMedGoogle Scholar
• Ansari AA, Fett JD, Caraway RD, Mayne AE, Onlamoon M, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin. Rev. Allergy Immunol.23, 301–324 (2002).
   PubMed Web of Science ®Google Scholar
• Warraich RS, Fett JD, Damasceno A et al. Impact of pregnancy related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am. Heart. J.150, 263–269 (2005).
   PubMed Web of Science ®Google Scholar
• Hill SL, Rose NR. The transition from viral to autoimmune myocarditis. Autoimmunity34, 169–176 (2001).
   PubMed Web of Science ®Google Scholar
• Hilfiker-Kleiner D, Kaminski K, Podewski E et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell128, 589–600 (2007).
   PubMed Web of Science ®Google Scholar
• Sliwa K, Blauwet L, Tibazarwa K et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy. A proof-of-concept pilot study. Circulation121(13), 1465–1473 (2010).
   PubMed Web of Science ®Google Scholar
• Elkayam U, Goland S. Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation121, 1463–1464 (2010).
   PubMed Web of Science ®Google Scholar
• Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am. Heart. J.152, 509–513 (2006).
   PubMed Web of Science ®Google Scholar
• Fett JD, Sannon H, Thelisma E, Sprunger T, Suresh V. Recovery from severe heart failure following peripartum cardiomyopathy. Int. J. Gynaecol. Obstet.104, 125–127 (2009).
   PubMed Web of Science ®Google Scholar
• American Heart Association. The AHA Guidelines and Scientific Statements Handbook. Fuster V (Ed.). Wiley-Blackwell, Oxford, UK (2009).
   Google Scholar
• Riordan J. Breastfeeding and Human Lactation (3rd Edition). Jones and Bartlett, MA, USA, 75–77 (2005).
   Google Scholar
• McMurray J, Swedberg K. Treatment of chronic heart failure: a comparison between the major guidelines. Eur. Heart J.27(15), 1773–1777 (2006).
   PubMed Web of Science ®Google Scholar
• Godsel LM, Leon JS, Engman DM. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr. Pharm. Des.9, 723–735 (2003).
   PubMed Web of Science ®Google Scholar
• Ohtsuka T, Hamada M, Hiasa G et al. Effect of β-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J. Am. Coll. Cardiol.37, 412–417 (2001).
   PubMed Web of Science ®Google Scholar
• Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. Am. J. Physiol. Heart Circ. Physiol.286(1), H83–H90 (2004).
   PubMed Web of Science ®Google Scholar
• Platten M, Youssef S, Hur EM et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates Th1 and Th17-mediated autoimmunity. Proc. Natl Acad. Sci. USA106, 14948–14953 (2009).
   PubMed Web of Science ®Google Scholar
• Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation99, 1091–1100 (1999).
   PubMed Web of Science ®Google Scholar
• Mason JW. Viral latency: a link between myocarditis and dilated cardiomyopathy? J. Mol. Cell Cardiol.34, 695–698 (2002).
   PubMed Web of Science ®Google Scholar
• Fujioka S, Kitaura Y, Deguchi H et al. Evidence of viral infection in the myocardium of American and Japanese patients with idiopathic dilated cardiomyopathy. Am. J. Cardiol.94, 602–605 (2004).
   PubMed Web of Science ®Google Scholar
• Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am. J. Obstet. Gynecol.193, 363–365 (2005).
   PubMed Web of Science ®Google Scholar
• Ambrosini G, Nanhornbque K, Pascoli I, Cester M, Cosmi E. Mirror syndrome due to coxsackie B virus associated to maternal peripartum cardiomyopathy. J. Perinat. Med.36, 453–454 (2008).
   PubMed Web of Science ®Google Scholar
• Fett JD. Diagnosis of viral cardiomyopathy by analysis of peripheral blood? Expert Opin. Ther. Targets12, 1073–1075 (2008).
   PubMed Web of Science ®Google Scholar
• Muroya T, Ikeda S, Yamasa T et al. High dose immune globulin therapy ameliorates peripartum cardiomyopathy with elevated serum antibody titer to influenza virus: case report of two patients. Med. Sci. Monit.16(2), CS11–CS14 (2010).
   PubMed Web of Science ®Google Scholar
• Halapas A, Pissimississ N, Lembessis P et al. Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications. Expert Opin. Ther. Targets12, 821–836 (2008).
   PubMed Web of Science ®Google Scholar
• Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur. Heart J. DOI: 10.1093/eurheartj/ehn296 (2008) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Wagner A, Deluigi CC et al. Presentation, patterns of myocardial damage and clinical course of viral myocarditis. Circulation114, 1581–1590 (2006).
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation109, 1250–1258 (2004).
   PubMed Web of Science ®Google Scholar
• Tavora F, Gonzalez-Cuyar LF, Dalal JS et al. Fatal parvoviral myocarditis: a case report and review of literature. Diagn. Pathol.3, 21 (2008).
   PubMed Web of Science ®Google Scholar
• Tam PY, Butler K, McMahon CJ. Incidental detection of parvovirus myocarditis at time of resection of discrete subaortic stenosis. Cardiol. Young16, 596–598 (2006).
   PubMed Web of Science ®Google Scholar
• Lamparter S, Schoppet M, Pankuweit S, Maisch B. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum. Pathol.34, 725–728 (2003).
   PubMed Web of Science ®Google Scholar
• Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5-year-old girl. Hum. Pathol.32, 342–345 (2001).
   PubMed Web of Science ®Google Scholar
• Letsas KP, Filippatos GS, Delimpasi S et al. Enterovirus-induced fulminant myocarditis and hemophagocytic syndrome. J. Infect.54, e75–e77 (2007).
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Zhu BL, Li DR et al. Epstein–Barr virus myocarditis as a cause of sudden death: two autopsy cases. Int. J. Legal Med.119, 231–235 (2005).
   PubMed Web of Science ®Google Scholar
• Frustaci A, Calabrese F, Chimenti C et al. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy. Chest122, 1348–1356 (2002).
   PubMed Web of Science ®Google Scholar
• Harder TC, Hufnagel M, Zahn K et al. New light cycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections. J. Clin. Microbiol.39, 4413–4419 (2001).
   PubMed Web of Science ®Google Scholar
• Goland S, Czer LS, Siegel RJ et al. Intravenous immunoglobulin in treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature. Can. J. Cardiol.24, 571–574 (2008).
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Villaneuva S, Holubkov R et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J. Am. Coll. Cardiol.34, 177–180 (1999).
   PubMed Web of Science ®Google Scholar
• Cooper LT, Virmani R, Chapman NM et al. National Institutes of Health-Sponsored Workshop on Inflammation and Immunity in Dilated Cardiomyopathy. Mayo Clin. Proc.81, 199–204 (2006).
   PubMed Web of Science ®Google Scholar
• Kaveri SV, Lacroix-Desmazes S, Bayry J. Clinical implications of basic research: the antinflammatory IgG. N. Engl. J. Med.359, 307–309 (2008).
   PubMed Web of Science ®Google Scholar
• Lindner J, Noutsias M, Lassner D et al. Adaptive immune responses against parvovirus B19 in patients with myocardial disease. J. Clin. Virol.44, 27–32 (2009).
   PubMed Web of Science ®Google Scholar
• Bock CT, Klingel K, Kanddolf R. Human parvovirus B19-associated myocarditis. N. Engl. J. Med.362, 1248–1249 (2010).
   PubMed Web of Science ®Google Scholar
• Fett JD, Christie LG, Carraway RD, Ansari AA, Sundstrom JB, Murphy JG. Unrecognized peripartum cardiomyopathy in Haitian women. Int. J. Gynaecol. Obstet.90, 161–166 (2005).
   PubMed Web of Science ®Google Scholar
• Vettori DV, Rohde LE, Clauself N. Asymptomatic left ventricular dysfunction in puerperal women: an echocardiographic-based study. Int. J. Cardiol. DOI: 10.1016/j.ijcard.2010.01.015 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Riad A, Westermann D, Escher F et al. Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo. Am. J. Physiol. Heart Circ. Physiol. DOI: 10.1152/ajpheart.01188.2009 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Jahns R, Boivin V, Hein L et al. Direct evidence for a β1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J. Clin. Invest.113, 1419–1429 (2004).
   PubMed Web of Science ®Google Scholar
• Freedmann NJ, Lefkowitz RJ. Anti-β1-adrenergic receptor antibodies and heart failure: causation, not just correlation. J. Clin. Invest.113, 1379–1382 (2004).
   PubMed Web of Science ®Google Scholar
• Fett JD, Ansari AA, Sundstrom JB, Combs GR Jr. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int. J. Cardiol.86, 311–316 (2002).
   PubMed Web of Science ®Google Scholar
• Muscaro-Blanco A, Alvarez K, Yu X et al. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity41, 442–453 (2008).
   PubMed Web of Science ®Google Scholar
• Ellis JE, Ansari AA, Fett JD et al. Inhibition of progenitor dendritic cell maturation by plasma from patients with peripartum cardiomyopathy: role in pregnancy-associated heart disease. Clin. Devel. Immunol.12, 265–273 (2005).
   PubMedGoogle Scholar
• Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K. C-reactive protein co-expresses with tumor necrosis factor-a in the myocardium in human dilated cardiomyopathy. Eur. J. Heart Fail.7, 748–754 (2005).
   PubMed Web of Science ®Google Scholar
• Lindberg E, Magnusson Y, Karason K, Andersson B. Lower levels of the host protective IL-10 in DCM – a feature of autoimmune pathogenesis? Autoimmunity41, 478–483 (2008).
   PubMed Web of Science ®Google Scholar
• Sliwa K, Forster O, Libhaber E et al. Peripartum dardiomyopathy: inflammatory markers as predictors of outcome in 100 propspectively studied patients. Eur. Heart J.27, 441–446 (2006).
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Knudsen M, Ilic A, Fine C, Sarvetnick N. Transforming growth factor-β inhibits coxsackievirus-mediated autoimmune myocarditis. Viral Immunol.19, 722–733 (2006).
   PubMed Web of Science ®Google Scholar
• Lucas JA, Zhang Y, Li P et al. Inhibition of transforming growth factor-β signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart. Am. J. Physiol. Heart Circ. Physiol.298, H424–H432 (2010).
   PubMed Web of Science ®Google Scholar
• Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. African–American women have a higher risk for developing peripartum cardiomyopathy. J. Am. Coll. Cardiol.55(7), 654–659 (2010).
   PubMed Web of Science ®Google Scholar
• Brar SS, Khan SS, Sandhu GK et al. Incidence, mortality and racial difference in peripartum cardiomyopathy. Am. J. Cardiol.100, 302–304 (2007).
   PubMed Web of Science ®Google Scholar
• Fett JD, Christie LG, Murphy JG. Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann. Int. Med.145, 30 –34 (2006).
   PubMed Web of Science ®Google Scholar
• Elkayam U, Tummala PP, Rao K et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N. Engl. J. Med.344(21), 1567–1571 (2001).
   PubMed Web of Science ®Google Scholar
• Habli M, O’Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am. J. Obstet. Gynecol.199(4), 415.e1–5 (2008).
   PubMed Web of Science ®Google Scholar
• Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am. J. Obstet. Gynecol.201(2), 171.e1–e5 (2009).
   PubMed Web of Science ®Google Scholar
• Fett JD, Fristoe KL, Welsh SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int. J. Gynecol. Obstet.109(1), 34–36 (2010).
   PubMed Web of Science ®Google Scholar